Advanced search
Publication Cover
Journal of Chemotherapy Volume 9, 1997 - Issue 6
Submit an article Journal homepage
93
Views
33
CrossRef citations to date
0
Altmetric
Articles

Do Vancomycin Serum Levels Predict Failures of Vancomycin Therapy or Nephrotoxicity in Cancer Patients?

K. Kralovicová
,
S. Spanik
,
J. Halko
,
J. Netriova
,
M. Studena-Mrazova
,
J. Novotny
,
S. Grausova
,
P. Koren
,
I. Krupova
,
A. Demitrovicova
,
E. Kukuckova
&
V. Krcmery
 show all
Pages 420-426 | Published online: 18 Jul 2013

References

  • EORTC Antimicrobial Study group. Grampositive bac-teremia in cancer patients from studies on empiric therapy of fever and neutropenia. Eur J Clin Microbiol Infect Dis 1993; 10, 4: 366-372.
  • EORTC Antimicrobial Therapy Cooperative group. Piperacillin/tazobactam plus amikacin versus ceftazidime plus amikacin in empiric therapy of febrile neutropenia in cancer patients. 33rd ICAAC, Annaheim, 1992, Abstr. 1143.
  • EORTC Antimicrobial Therapy Cooperative group. Amikacin plus ceftriaxone once daily versus in multiple daily doses in empiric therapy for febrile granulocytopenic patients. Ann Infect Med 1993; 117, 6: 377-382.
  • EORTC Antimicrobial Therapy Cooperative group. Meropenem versus ceftazidime plus amikacin in initial thera-py of infections in febrile neutropenia. 34th ICAAC, Orlando, 1996, Abstract No. 898.
  • EORTC Antimicrobial Therapy Cooperative group. Pefloxacin plus penicillin in prevention of infections in granu-locytopenic patients. A randomized placebo-controlled trial. JAMA 1995; 69, 4: 288-296.
  • Murray B. Vancomycin resistance in enterococci. Clin Infect Dis 1995; 20, 2: 35–39.
  • Kline MW, Mason EO. Methicillin-resistant S. aureus: pediatric perspective. Pediatr Clin North Am 1988; 35, 7: 613-624.
  • Guiot JWE. Bacteremia due to penicillin-resistant viri-dans streptococci in cancer patients. Clin Infect Dis 1995; 20, 2: 107–113.
  • Menichetti F, Del Favero A. The role of grampositive therapy in the neutropenic patient. J Antimicrob Chemother 1991; 27: 51–60.
  • Welty TE, Copa AK. Impact of vancomycin therapeutic drug monitoring on particular care. Ann Pharmacother 1994; 24: 1335–1339.
  • Krcmery V Jr, Trupl J. Breakthrough bacteremia due to vancomycin-resistant S. epidermidis in cancer patients after quinolone prophylaxis. Eur J Clin Microbiol Infect Dis 1996; 12, 1: 28-33.
  • Chang R, Lieu L, Magalowkin M. A prospective study of vancomycin pharmacokinetics and dosage requirements in pediatric cancer patients. Pediatr Infect Dis J 1994; 13: 969–974.
  • Pryka R. Vancomycin serum concentration monitoring - a combined debate. Ann Pharmacother 1994; 28: 1397–1399.
  • Saunders NJ. Why monitor peak vancomycin serum concentrations? Lancet 1994; 344: 1748-1750.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.